Jul 01, 2009
New York, New York, July 2009 - The Rogosin Institute has received a $750,000 grant from Board member, William Macaulay and his wife, Linda, to be used to build a new dialysis center in Queens, NY.
New York, New York, July 2009 - The Rogosin Institute has received a $750,000 grant from Board member, William Macaulay and his wife, Linda, to be used to build a new dialysis center in Queens, NY.

The new center will be located in Auburndale, Queens and will cost $3.5 million dollars to build. When completed in 2010, the Center will have the capability to treat 60 patients daily and will include transplantation screening, intake and pre-surgery education, among other healthcare services, provided by The Rogosin Institute. With the prevalence of chronic kidney disease rising rapidly all across America, the Center will fill an important need for individuals with these problems in Queens and beyond on Long Island. Its launching is an integral part of Rogosin's commitment to providing the best in kidney care for all New Yorkers. 

Rogosin is an independent not-for-profit treatment and research center affiliated with NewYork-Presbyterian Hospital (NYPH), Weill Cornell Medical College. It is a Sponsored Member of the NewYork-Presbyterian Healthcare System. It is one of the nation's leading centers for kidney disease, providing services from early stage disease to more serious problems requiring dialysis and transplantation. The Institute is unique in its combination of the best in clinical care with research into new and better ways to prevent and treat kidney disease, as well as the diseases that contribute to it, such as hypertension, diabetes, and lipid disorders. Rogosin's programs have played a major role in NYPH's #2 ranking nationally in the treatment of kidney disease.* 

Mr. Macaulay is Chairman and Chief Executive Officer of First Reserve Corporation which he co-founded in 1983. Mr. Macaulay has been a member of the Rogosin Institute Board since 2003 and serves as its Vice Chairman.

The grant stipulates that Rogosin must raise $750,000 in matching funds by the end of 2009.

"We are deeply grateful that the Macaulays have given us this generous grant that will expand kidney care services in New York," said Barry Smith, MD, Director of the Rogosin Institute. "As a leader in the treatment of kidney disease, we know there is a great need for education, treatment and prevention programs throughout the New York metropolitan area and this facility will help us meet that need. The provision of such service is the core mission of The Institute."

For more information or to contribute to the challenge grant, contact The Rogosin Institute Development Office at 212-746-1552.

*Best Hospitals (2009), ranked by US News & World Report.
Back to News Listing